Microbiome-derived program (Vedanta Biosciences)

N/A

Report date: 2025/03/20 15:56:15

Base Information

Drug NameMicrobiome-derived program (Vedanta Biosciences)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionImmunostimulantsMicrobiome modulators
TargetsUpdating
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVedanta Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesVedanta Biosciences Inc
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A